Search Results 2581-2590 of 16863 for Epilepsy (Partial Onset)
Comprehensive Skull Base Clinic. Deep brain stimulation. Epilepsy. Esthesioneuroblastoma. Meningioma. Pituitary Network Association. Clinical trials. Dr.
Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Mayo Clinic researchers develop new AI tools to ...
Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. From fear to a phone call in 2 ...
MSC-NTF cells are a novel cell-therapeutic approach which is expected to effectively deliver Neurotrophic factors, which are potent survival factors for neurons ...
About this study. The primary purpose of this study is to evaluate the efficacy of AL001 compared with placebo in carriers of progranulin gene (GRN) ...
To compare with a randomized trial (n=15 per treatment group), effects of colesevelam and placebo treatment, on colonic transit, bowel functions, permeability ...
... duration or severity). The patient demonstrated compliance with the electronic diary during the baseline period by entry of headache data at a minimum of 75 ...
Intractable seizures while on adequate anticonvulsant therapy; more than 1 seizure per month for the past 2 months. Patients with definitive leptomeningeal ...
A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.
Rochester, Minn. The purpose o fthis study. A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.